Dr. Rosie D. Lyles, MD, MHA, MSc is the Head of Clinical Affairs for the Clorox Professional Products Company where she serves as a research fellow and primary medical science liaison for thehealthcare business, supporting all scientific research as well as clinical and product intervention design and development. Dr. Lyles previously served as a physician researcher and study directorfor multiple epidemiologic research initiatives in the Division of Infectious Diseases at the Cook County Health and Hospitals System, investigating healthcare-associated infections with a particular focus on the epidemiology and prevention of multidrug-resistant organismssuch as Clostridium difficile (C. diff), Methicillin-resistant Staphylococcus aureus (MRSA), and carbapenemase-producing Enterobacteriaceae (CRE)in intensive care units andin long-term acute care hospitals. She has directed numerous clinical studies and interventions for the Centers for Disease Control and Prevention (CDC) and the Chicago Antimicrobial Resistance and Infection Prevention Epicenterwith numerous peer-reviewed journal articles related to infectious disease epidemiology.
Dr. Lyles received her bachelor of science from Texas Woman’s University; medical degree from St. Matthew’s University School of Medicine and holds a Master of Health Service Administration from St. Joseph College and Master of Science in Clinical Research and Translational Sciences through the University of Illinois at Chicago. She is an active member in numerous infection prevention societies (i.e. Association of Professionals in Infection Control (APIC), the Infectious Disease Society of America (IDSA), U.S. Stakeholder Forum on Antibiotic Resistance, andthe Society for Healthcare Epidemiology of America (SHEA)), on the Medial Advisory Board for C. Diff Foundation, Co-Chair for AHE Industry Advisory Task Force and serve as a peer reviewer for the National Institutes of Health (NIH), New England Journal of Medicine, and American Journal of Infection Control.
Bacterial and Mycoses infections; Antibiotic resistance; Nosocomial infections; Epidemiology and prevention of health care-associated infections; Molecular epidemiology.